Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Resveratrol attenuates ICAM-1 expression and monocyte adhesiveness to TNF-α-treated endothelial cells: evidence for an anti-inflammatory cascade mediated by the miR-221/222/AMPK/p38/NF-κB pathway.

Liu CW, Sung HC, Lin SR, Wu CW, Lee CW, Lee IT, Yang YF, Yu IS, Lin SW, Chiang MH, Liang CJ, Chen YL.

Sci Rep. 2017 Mar 24;7:44689. doi: 10.1038/srep44689.

2.

Resveratrol activates endogenous cardiac stem cells and improves myocardial regeneration following acute myocardial infarction.

Ling L, Gu S, Cheng Y.

Mol Med Rep. 2017 Mar;15(3):1188-1194. doi: 10.3892/mmr.2017.6143. Epub 2017 Jan 25.

3.

Polyphenol compounds and PKC signaling.

Das J, Ramani R, Suraju MO.

Biochim Biophys Acta. 2016 Oct;1860(10):2107-21. doi: 10.1016/j.bbagen.2016.06.022. Epub 2016 Jun 29. Review.

PMID:
27369735
4.

Finding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging Molecules.

Kumar S, Lombard DB.

F1000Res. 2016 Mar 29;5. pii: F1000 Faculty Rev-406. doi: 10.12688/f1000research.7821.1. eCollection 2016. Review.

5.

Resveratrol and Ophthalmic Diseases.

Abu-Amero KK, Kondkar AA, Chalam KV.

Nutrients. 2016 Apr 5;8(4):200. doi: 10.3390/nu8040200. Review.

6.

Resveratrol increases F508del-CFTR dependent salivary secretion in cystic fibrosis mice.

Dhooghe B, Bouckaert C, Capron A, Wallemacq P, Leal T, Noel S.

Biol Open. 2015 Jun 19;4(7):929-36. doi: 10.1242/bio.010967.

7.

Resveratrol ameliorates renal damage, increases expression of heme oxygenase-1, and has anti-complement, anti-oxidative, and anti-apoptotic effects in a murine model of membranous nephropathy.

Wu CC, Huang YS, Chen JS, Huang CF, Su SL, Lu KC, Lin YF, Chu P, Lin SH, Sytwu HK.

PLoS One. 2015 May 8;10(5):e0125726. doi: 10.1371/journal.pone.0125726. eCollection 2015.

8.

VitisCyc: a metabolic pathway knowledgebase for grapevine (Vitis vinifera).

Naithani S, Raja R, Waddell EN, Elser J, Gouthu S, Deluc LG, Jaiswal P.

Front Plant Sci. 2014 Dec 9;5:644. doi: 10.3389/fpls.2014.00644. eCollection 2014.

9.

Resveratrol post-transcriptionally regulates pro-inflammatory gene expression via regulation of KSRP RNA binding activity.

Bollmann F, Art J, Henke J, Schrick K, Besche V, Bros M, Li H, Siuda D, Handler N, Bauer F, Erker T, Behnke F, Mönch B, Härdle L, Hoffmann M, Chen CY, Förstermann U, Dirsch VM, Werz O, Kleinert H, Pautz A.

Nucleic Acids Res. 2014 Nov 10;42(20):12555-69. doi: 10.1093/nar/gku1033. Epub 2014 Oct 28.

10.

Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia.

Ma X, Sun Z, Liu Y, Jia Y, Zhang B, Zhang J.

Neural Regen Res. 2013 Aug 5;8(22):2050-9. doi: 10.3969/j.issn.1673-5374.2013.22.004.

11.

Alcohol consumption and risk of death in male physicians with heart failure.

Petrone AB, Gaziano JM, Djoussé L.

Am J Cardiol. 2014 Oct 1;114(7):1065-8. doi: 10.1016/j.amjcard.2014.07.021. Epub 2014 Jul 18.

12.

Resveratrol: a supplementation for men or for mice?

Ponzo V, Soldati L, Bo S.

J Transl Med. 2014 Jun 3;12:158. doi: 10.1186/1479-5876-12-158.

13.

Resveratrol levels and all-cause mortality in older community-dwelling adults.

Semba RD, Ferrucci L, Bartali B, Urpí-Sarda M, Zamora-Ros R, Sun K, Cherubini A, Bandinelli S, Andres-Lacueva C.

JAMA Intern Med. 2014 Jul;174(7):1077-84. doi: 10.1001/jamainternmed.2014.1582.

14.

Method Validation for the One-Month Stability Study of trans-Resveratrol in Human Plasma.

Iranshahy M, Mohammadpoor AH, Hassanzadeh-Khayyat M, Iranshahi M.

Jundishapur J Nat Pharm Prod. 2013 Spring;8(2):65-9. Epub 2013 May 4.

15.

Milk, dairy products, and their functional effects in humans: a narrative review of recent evidence.

Visioli F, Strata A.

Adv Nutr. 2014 Mar 1;5(2):131-43. doi: 10.3945/an.113.005025. Review.

16.

Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation.

Baczko I, Liknes D, Yang W, Hamming KC, Searle G, Jaeger K, Husti Z, Juhasz V, Klausz G, Pap R, Saghy L, Varro A, Dolinsky V, Wang S, Rauniyar V, Hall D, Dyck JR, Light PE.

Br J Pharmacol. 2014 Jan;171(1):92-106. doi: 10.1111/bph.12409.

17.

Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway.

Li W, Ma J, Ma Q, Li B, Han L, Liu J, Xu Q, Duan W, Yu S, Wang F, Wu E.

Curr Med Chem. 2013;20(33):4185-4194.

18.

Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases.

Rosenbaugh EG, Savalia KK, Manickam DS, Zimmerman MC.

Am J Physiol Regul Integr Comp Physiol. 2013 Jun 1;304(11):R917-28. doi: 10.1152/ajpregu.00395.2012. Epub 2013 Apr 3. Review.

19.

Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Tomé-Carneiro J, Larrosa M, González-Sarrías A, Tomás-Barberán FA, García-Conesa MT, Espín JC.

Curr Pharm Des. 2013;19(34):6064-93. Review.

20.

PKC activation by resveratrol derivatives with unsaturated aliphatic chain.

Pany S, Majhi A, Das J.

PLoS One. 2012;7(12):e52888. doi: 10.1371/journal.pone.0052888. Epub 2012 Dec 21.

Supplemental Content

Support Center